Donor mice pre-treated with plasmid DNA encoding the FLT3L protein exhibited a near ten-fold increase in pDC and mDCs, and the pDC + mDC combination exhibited superior anti-tumor efficacy compared to either DC subset alone [169]. The gene discussed is FLT3LG; the disease is neoplasm.